Pharmacokinetics and Pharmacodynamics of Biological Drugs

Education facts

Code: 3FB037

The course provides a detailed picture of how different biological medicines are distributed and eliminated and how different target structures and disease states can affect their dose-concentration-effect relationship. Through lectures and workshops, the course sheds light on how the relationships affect both drug development and use, in comparison with more traditional drugs. The course focuses on protein medicines and antibodies but also covers other types of biological medicines such as peptides, oligonucleotides, vaccines and cell therapies. We also discuss how knowledge about the dose-response relationships of biological medicines in preclinical studies is used to define clinical study design.

Entry requirements

150 credits which of 120 credits in biomedicine, biology, pharmaceutical science, chemistry and/or science/engineering. Prior studies should contain 5 credits in pharmacokinetics and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Education offerings

Each offering has its own dates and conditions. Closed offerings are retained as history and do not mean that a new application is open.

• Pharmacokinetics and Pharmacodynamics of Biological Drugs

  Uppsala University

  Start date: 2 December 2026

  End date: 17 January 2027

  Pace of study: 100 %